ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Kidney transplantation"

  • 2017 American Transplant Congress

    Warm Ischemic Time as an Additive Predictor of Graft Survival in KDPI/KDRI Era of Kidneys from Donors After Cardiac Death: A Single-Center Experience Over Three Decades.

    M. Kusaka,1 Y. Kubota,1 H. Takahashi,2 H. Sasaki,1 M. Takenaka,1 N. Fukami,1 T. Kenmochi,3 R. Shiroki,1 K. Hoshinaga.1

    1Urology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan; 2Division of Medical Statistics, Fujita Health University School of Medicine, Toyoake, Aichi, Japan; 3Organ Transplant Surgery, Fujita Health University School of Medicine, Toyoake, Aichi, Japan

    It is important to predict the outcome of grafts prior to kidney transplantation and establish an appropriate allocation system, particularly to consider expanded criteria donors…
  • 2017 American Transplant Congress

    Access to Living Donor Kidney Transplantation in Nepal.

    P. Shrestha,1 S. Rasmussen,1 A. Thomas,1 S. Ferguson,2 A. Massie,1 D. Segev,1 P. Shrestha.3

    1JHU, Baltimore; 2Grinnell College, Grinnell; 3Human Organ Transplant Center, Bhaktapur, Nepal

    Kidney transplantation is a relatively new and rapidly growing treatment modality in Nepal. Disparities in access to care are greatly amplified in a developing country…
  • 2017 American Transplant Congress

    Malignancy in Patients Undergoing Simultaneous Heart-Liver and Heart-Kidney Transplant.

    A. Chin, A. Habertheuer, A. Chou, M. Acker, M. Williams, P. Atluri, C. Bermudez, P. Vallabhajosyula.

    University of Pennsylvania, Philadelphia, PA

    Purpose: While evidence suggests that patients undergoing simultaneous heart-liver and heart-kidney transplant may have improved immunoprotection from allograft rejection versus patients undergoing heart transplant only,…
  • 2017 American Transplant Congress

    Titers of Blood Group B Patients Using Non-A1 Reagent/Donor Cells for the Purpose of ABO Incompatible Kidney Transplantation.

    D. King, M. Aguilucho, M. Marchioni, B. Figueiredo, I. Okere, P. Rao.

    NJ Sharing Network, New Providence

    Background: Blood group B patients are eligible to receive offers from non-A1 or non-A1B kidney donors. Current practice in many institutions involves performing these titers…
  • 2017 American Transplant Congress

    Endovascular Management of Transplant Renal Artery Stenosis: A Safe and Effective Treatment.

    A. Cavalcanti,1 M. Durao,1,2 B. Santos,1,2 E. Tonato,1,2 M. Doher,2 N. Guimaraes-Souza,1,2 L. Moreira Valle,1 B. Affonso,1 F. Nasser,1 A. Pacheco-Silva.1,2

    1Nephrology, Hospital Israelita Albert Einstein, São Paulo, Brazil; 2Nephrology, Universidade Federal de São Paulo, São Paulo, Brazil

    Background:Transplant Renal Artery Stenosis (TRAS) is a low incidence complication, but if untreated, can lead to graft failure, refractory hypertension (HT) and reduced life expectancy.…
  • 2017 American Transplant Congress

    Increased Expression of Fibrillin-1 and Presence of Fibroblastic Reticular Cells in Treg-Rich Organized Lymphoid Structures (TOLS) of Accepted Kidney Allografts.

    A. Ayyar, C. Yang, D. Ndishabandi, R. White, P. Russell, J. Madsen, R. Colvin, A. Alessandrini.

    Center for Transplantation Sciences, Massachusetts General Hospital, Boston, MA

    Background: Fibrillin-1, found in connective tissue, plays a role in the sequestration of TGF-b, and is produced by fibroblastic reticular cells (FRCs). It has been…
  • 2017 American Transplant Congress

    Direct Comparison of Hypothermic and Normothermic Organ Preservation in a Porcine Ex-Vivo Kidney Model.

    N. Vallant,1,2 B. Sandhu,1 N. Wolfhagen,1 C. Pusey,1 V. Papalois.1

    1Renal and Transplant Department, Imperial College, London, United Kingdom; 2Department of Visceral-, Transplant- and Thoracic Surgery, Medical University, Innsbruck, Austria

    Background: Hypothermic machine perfusion is a well established method for deceased donor organ preservation as well as pre-transplant assessment and preconditioning. Recent translational and clinical…
  • 2017 American Transplant Congress

    Effect of Everolimus-Based Regimen on Graft Outcomes in Kidney Transplant Recipients with Diabetes at Baseline: Post-Hoc Analysis from the ELEVATE Study.

    J. de Fijter,1 H. Holdaas,1 J. Sanders,1 S. Sundar,1 F. Bemelman,1 P. Lopez,2 G. Bader,2 J. Cruzado,1 M. van der Giet.1

    1ELEVATE Study Group, Leiden, Netherlands; 2Novartis Pharma AG, Basel, Switzerland

    Purpose: Presence of diabetes may have adverse impact on graft outcome in kidney transplant recipients (KTxRs). This post-hoc analysis from the ELEVATE study compared the…
  • 2017 American Transplant Congress

    The Efficacy and Safety of Plaquenil in Kidney Transplants Patients with Lupus.

    S. Rhazouani,1,4 S. Anwar,2 D. Brennan,1 K. Lentine,3 K. Venkatachalam,1 A. Malone,1 T. Alhamad.1

    1Washington University, Saint Louis; 2Freman Hospital, New Castle, United Kingdom; 3Saint Louis University, Saint Louis; 4Cleveland Clinic Foundation, Weston

    Background: Hydroxychloroquine, also known as Plaquenil ( PLQ) is an antimalarial drug with immunomodulatory action. Recent studies have demonstrated a protective effect of PLQ in…
  • 2017 American Transplant Congress

    Lipid Abnormalities and Cardiovascular Events After Early Conversion to Everolimus in Kidney Transplant Recipients with Pretransplant Diabetes: 24-Month Analysis from Elevate Study.

    M. van der Giet,1 J. de Fijter,1 F. Oppenheimer,1 G. Russ,1 P. Lopez,2 G. Bader,2 J. Cruzado,1 H. Holdaas.1

    1ELEVATE Study Group, Berlin, Germany; 2Novartis Pharma AG, Basel, Switzerland

    PURPOSE: Pretransplant (preTx) diabetes is an independent risk factor for cardiovascular (CV) events, and posttransplant (post-Tx) hyperlipidemia further increases CV risk. To analyze the influence…
  • « Previous Page
  • 1
  • …
  • 346
  • 347
  • 348
  • 349
  • 350
  • …
  • 531
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2026 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences